Candida tropicalis from veterinary and human sources shows similar in vitro hemolytic activity, antifungal biofilm susceptibility and pathogenesis against Caenorhabditis elegans

scientific article published on 28 July 2016

Candida tropicalis from veterinary and human sources shows similar in vitro hemolytic activity, antifungal biofilm susceptibility and pathogenesis against Caenorhabditis elegans is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.VETMIC.2016.07.022
P698PubMed publication ID27527785

P50authorDébora de Souza Collares Maia Castelo-BrancoQ82065658
Jonathas Sales OliveiraQ85485870
P2093author name stringJosé Júlio Costa Sidrim
Marcos Fábio Gadelha Rocha
Raimunda Sâmia Nogueira Brilhante
Rossana de Aguiar Cordeiro
Rosana Serpa
Vandbergue Santos Pereira
Antônio José de Jesus Evangelista
Waldemiro Aquino Pereira-Neto
Aline Lobão da Silva
Felipe Rodrigues Magalhães de Aguiar
P2860cites workMechanisms of Candida biofilm drug resistanceQ26827521
ImageJ for microscopyQ28253317
Antifungal chemical compounds identified using a C. elegans pathogenicity assayQ28469125
Paradoxical growth of Candida albicans in the presence of caspofungin is associated with multiple cell wall rearrangements and decreased virulenceQ30570494
Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistanceQ33258644
Comparison of human and soil Candida tropicalis isolates with reduced susceptibility to fluconazoleQ34230214
Hemolytic factor production by clinical isolates of Candida speciesQ34372145
Interindividual variability and intraindividual stability of oral fungal microbiota over time.Q35189200
Caenorhabditis elegans: a simple nematode infection model for Penicillium marneffeiQ35287268
Biofilm formation by and antifungal susceptibility of Candida isolates from urineQ35690002
Fungal biofilm resistanceQ35821475
Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida speciesQ36094887
Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolatesQ37392907
Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection modelQ37410095
Insights into Candida tropicalis nosocomial infections and virulence factors.Q37950850
Lipolytic enzymes involved in the virulence of human pathogenic fungiQ38123155
Comparison of the antifungal activity of micafungin and amphotericin B against Candida tropicalis biofilmsQ40687144
Production of biofilm by Candida and non-Candida spp. isolates causing fungemia: comparison of biomass production and metabolic activity and development of cut-off pointsQ41738290
Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients.Q43256157
Secreted aspartic proteases of Candida albicans, Candida tropicalis, Candida parapsilosis and Candida lusitaniae. Inhibition with peptidomimetic inhibitorsQ43588602
Characteristics of biofilm formation by Candida tropicalis and antifungal resistanceQ46773185
Candida tropicalis isolates obtained from veterinary sources show resistance to azoles and produce virulence factorsQ46791655
Enzymatic and hemolytic activity in different Candida species.Q46909471
A modified microtiter-plate test for quantification of staphylococcal biofilm formationQ47326225
Production of haemolytic factor by clinical isolates of Candida tropicalis.Q50532476
Biofilm formation by five species of Candida on three clinical materialsQ84335623
P921main subjectbiofilmQ467410
Caenorhabditis elegansQ91703
Candida tropicalisQ143138
P1104number of pages7
P304page(s)213-219
P577publication date2016-07-28
P1433published inVeterinary MicrobiologyQ15761011
P1476titleCandida tropicalis from veterinary and human sources shows similar in vitro hemolytic activity, antifungal biofilm susceptibility and pathogenesis against Caenorhabditis elegans
P478volume192